Mount Sinai Unveils AI Center to Accelerate Small Molecule Drug Discovery

“By integrating artificial intelligence with cutting-edge chemistry and biology, we can dramatically accelerate drug discovery and develop new treatments for some of the most complex and pressing diseases.” – News Medical.

“Unlike conventional drug discovery, which can take years and cost billions, AI-driven approaches enable researchers to rapidly navigate a vast chemical landscape to pinpoint promising drug candidates—bringing treatments to patients faster.”